Publications by authors named "Ram Shrivastava"

Claim this Profile
I
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Maurizio Fava, Gregory M Asnis, Ram K Shrivastava, Bruce Lydiard, Bijan Bastani

J Clin Psychiatry· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Maurizio Fava, Gregory M Asnis, Ram Shrivastava, Bruce Lydiard, Bijan Bastani

J Clin Psychopharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder.
Stuart A Montgomery, John P Feighner, Lev Sverdlov, Ram K Shrivastava, Lynn A Cunningham

Int J Neuropsychopharmacol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
Douglas E Feltner, Jerri G Crockatt, Steven J Dubovsky, Cal K Cohn, Ram K Shrivastava

J Clin Psychopharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
Alan D Feiger, Jon F Heiser, Ram K Shrivastava, Kenneth J Weiss, Ward T Smith

J Clin Psychiatry· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis